Your browser is no longer supported. Please, upgrade your browser.
Settings
CRMD CorMedix, Inc. daily Stock Chart
CRMD [NYSE]
CorMedix, Inc.
Index- P/E- EPS (ttm)-0.50 Insider Own1.70% Shs Outstand110.95M Perf Week-14.21%
Market Cap187.51M Forward P/E- EPS next Y-0.27 Insider Trans38.06% Shs Float100.34M Perf Month-12.44%
Income-39.30M PEG- EPS next Q-0.08 Inst Own21.00% Short Float12.39% Perf Quarter53.64%
Sales0.50M P/S375.01 EPS this Y7.80% Inst Trans48.18% Short Ratio4.03 Perf Half Y261.96%
Book/sh-0.10 P/B- EPS next Y35.70% ROA-424.30% Target Price4.75 Perf Year201.84%
Cash/sh0.06 P/C29.30 EPS next 5Y- ROE- 52W Range0.17 - 2.74 Perf YTD31.01%
Dividend- P/FCF- EPS past 5Y-15.10% ROI- 52W High-32.85% Beta2.88
Dividend %- Quick Ratio0.40 Sales past 5Y- Gross Margin37.20% 52W Low969.15% ATR0.25
Employees14 Current Ratio0.40 Sales Q/Q300.00% Oper. Margin- RSI (14)49.36 Volatility17.79% 12.44%
OptionableYes Debt/Eq- EPS Q/Q34.20% Profit Margin- Rel Volume1.55 Prev Close1.69
ShortableYes LT Debt/Eq- EarningsMar 18 AMC Payout- Avg Volume3.08M Price1.84
Recom2.00 SMA20-4.76% SMA509.63% SMA20099.91% Volume2,916,256 Change8.88%
Dec-06-18Initiated ROTH Capital Buy $6
Sep-25-17Reiterated H.C. Wainwright Buy $3 → $4
Aug-10-17Reiterated Rodman & Renshaw Buy $5 → $3
May-05-17Reiterated Rodman & Renshaw Buy $6 → $5
Nov-11-16Reiterated FBR & Co. Outperform $6 → $4
Mar-17-16Reiterated FBR Capital Outperform $7 → $6
Mar-03-16Initiated FBR Capital Outperform $7
Nov-16-15Reiterated ROTH Capital Neutral $2.75 → $2.50
Oct-29-15Reiterated ROTH Capital Neutral $4.50 → $2.75
May-06-15Downgrade ROTH Capital Buy → Neutral $2.50 → $7.50
Dec-08-14Reiterated ROTH Capital Buy $3 → $2.50
Oct-03-11Downgrade Maxim Group Buy → Hold
Feb-14-19 01:47PM  Here's Why CorMedix Dropped as Much as 27.1% Today Motley Fool -27.94%
08:15AM  CorMedix Inc. Announces FDA Meeting Update ACCESSWIRE
Feb-13-19 09:00AM  Biotech and Cannabis Stocks That Are Emerging ACCESSWIRE -6.79%
Feb-12-19 02:25PM  These Healthcare Stocks Could Surpass Investor Expectations ACCESSWIRE +24.41%
Jan-30-19 08:15AM  Cormedix Inc. Announces Topline Analysis of the Full Data Set of Phase 3 Lock-It-100 Study Reinforces the Interim Results ACCESSWIRE +5.62%
Jan-29-19 07:35AM  Factors of Influence in 2019, Key Indicators and Opportunity within The Hain Celestial Group, Allegheny Technologies, NVR, Greif, CorMedix, and Enzo Biochem New Research Emphasizes Economic Growth GlobeNewswire
Jan-21-19 08:41AM  Options Traders Expect Huge Moves in CorMedix (CRMD) Stock Zacks
Jan-17-19 09:26AM  These 4 Healthcare Stocks Are Raising Expectations ACCESSWIRE
08:00AM  Cormedix Inc. Announces Highly Statistically Significant Topline Results For Neutrolin(R) From The Interim Analysis Of The Phase 3 Lock-It-100 Study ACCESSWIRE
Jan-16-19 04:15PM  CorMedix Inc. Announces Resignation of Member of Its Board of Directors ACCESSWIRE
08:00AM  Today's Research Reports on Trending Tickers: Incyte and CorMedix ACCESSWIRE
Jan-09-19 06:30AM  This Stock Generated 25X Returns In Just Five Years: Could BTCY Be At The Same Crossroads? ACCESSWIRE
Jan-03-19 03:15PM  Cormedix Announces Closing of $7.5 Million Senior Secured Convertible Debt Financing ACCESSWIRE
Dec-21-18 08:58AM  Implied Volatility Surging for CorMedix (CRMD) Stock Options Zacks -8.80%
Dec-11-18 09:00AM  CBD and Biotech Plays on The Rise ACCESSWIRE
Dec-10-18 03:10PM  Cormedix Receives Approval to Sell $5.4 Million of NOL Tax Benefits Through the New Jersey Economic Development Authority Program ACCESSWIRE
Nov-28-18 11:50AM  Biomedical Trends Fuel New Momentum For Healthcare Stocks; Premier Health Group, Inc. (OTC: PHGRF) (CSE: PHGI), Alliqua BioMedical, BioScrip, Coremedix ACCESSWIRE +11.67%
08:10AM  Consolidated Research: 2018 Summary Expectations for Kadmon, Overstock, AECOM, Steelcase, CorMedix, and Corindus Vascular Robotics Fundamental Analysis, Key Performance Indications GlobeNewswire
Nov-27-18 11:00AM  CBD and Biotech Stocks to Watch ACCESSWIRE -7.69%
Nov-15-18 03:28PM  CorMedix: 3Q Earnings Snapshot Associated Press -17.69%
Nov-14-18 03:10PM  CorMedix Inc. Reports Third Quarter Financial Results and Provides Business Update ACCESSWIRE
Nov-06-18 03:00PM  CorMedix Inc. to Report Third Quarter 2018 Financial Results on Wednesday, November 14 ACCESSWIRE
Nov-02-18 11:20AM  3 Healthcare Stocks Using Technology To Boost Growth ACCESSWIRE +20.95%
Nov-01-18 08:30AM  Penny Stocks to Buy Using Technical Analysis for November 2018 Investopedia
Oct-18-18 09:15AM  Recent Analysis Shows Lantheus, Editas Medicine, CorMedix, DXP Enterprises, Peabody Energy, and CommScope Holding Market Influences Renewed Outlook, Key Drivers of Growth GlobeNewswire -15.79%
08:00AM  CorMedix Inc. Clarifies That No New Shares Are Being Issued In Connection With Its Recently Filed Form S-3 Registration Statement ACCESSWIRE
Oct-01-18 07:13AM  What Kind Of Shareholders Own CorMedix Inc (NYSEMKT:CRMD)? Simply Wall St. +22.85%
Aug-31-18 04:15PM  CorMedix Announces NYSE American Acceptance of Plan to Regain Listing Compliance ACCESSWIRE +5.44%
Aug-30-18 08:00AM  CorMedix Inc. to Present at The 20th Annual Rodman & Renshaw Global Investment Conference ACCESSWIRE +7.52%
Aug-27-18 07:40AM  Analysis: Positioning to Benefit within C&J Energy Services, LivePerson, Kadmon, Cara Therapeutics, CorMedix, and Second Sight Medical Products Research Highlights Growth, Revenue, and Consolidated Results GlobeNewswire +9.44%
Aug-14-18 06:09PM  CorMedix: 2Q Earnings Snapshot Associated Press -8.20%
04:05PM  CorMedix Inc. Reports Second Quarter Financial Results and Provides Business Update ACCESSWIRE
02:30PM  CorMedix Inc. to Host Earnings Call ACCESSWIRE
Aug-02-18 08:00AM  CorMedix Inc. to Report Second Quarter 2018 Financial Results on Tuesday, August 14 ACCESSWIRE +15.37%
Jul-26-18 08:10AM  Today's Research Reports on Stocks to Watch: USANA Health Sciences and CorMedix ACCESSWIRE +31.90%
Jul-25-18 07:30AM  Cormedix Inc. Announces Positive Results Of Its Neutrolin(R) Phase 3 Lock-It-100 Study Based On Recommendation By Independent Data Safety Monitoring Board ACCESSWIRE +16.43%
Jul-24-18 07:55AM  Free Research Reports on CorMedix and Three More Biotech Stocks ACCESSWIRE
Jun-26-18 07:30AM  Report: Exploring Fundamental Drivers Behind Chegg, C.H. Robinson Worldwide, Republic Services, CorMedix, Burlington Stores, and Etsy New Horizons, Emerging Trends, and Upcoming Developments GlobeNewswire
Jun-25-18 07:05AM  Today's Free Research Reports Coverage on CorMedix and Three More Biotech Stocks ACCESSWIRE -6.37%
Jun-20-18 07:30AM  Cormedix Inc. Completes Review and Source Verification of Phase 3 Lock-It 100 Data For Neutrolin(R) ACCESSWIRE
Jun-19-18 04:15PM  Cormedix Inc. Receives a Continued Listing Standard Notice from the NYSE American ACCESSWIRE
May-30-18 08:35AM  Benzinga Pro's 5 Stocks To Watch Today Benzinga +23.78%
May-29-18 04:30PM  CorMedix, Inc. Reports Progress on LOCK- IT 100 Data Review and Appoints Paul Chew as Consultant Advisor CMO ACCESSWIRE
May-25-18 04:25PM  With A -26.58% Earnings Drop, Did CorMedix Inc (NYSEMKT:CRMD) Really Underperform? Simply Wall St. +5.39%
May-15-18 04:05PM  Cormedix Inc. Reports First Quarter Financial Results and Provides Business Update ACCESSWIRE
May-09-18 08:20AM  Report: Exploring Fundamental Drivers Behind CorMedix, U.S. Silica, Zoetis, Kansas City Southern, Bemis, and Flowserve New Horizons, Emerging Trends, and Upcoming Developments GlobeNewswire
08:00AM  CorMedix Inc. to Report First Quarter 2018 Financial Results on Tuesday, May 15 ACCESSWIRE
Apr-27-18 08:00AM  CorMedix Revises Timeline and Announces Changes to Lock-It-100 Study Management ACCESSWIRE +6.51%
Mar-20-18 05:00PM  CorMedix Inc. Makes NYSE American Section 610(b) Public Announcement ACCESSWIRE -12.63%
Mar-19-18 04:05PM  Cormedix Inc. Reports Fourth Quarter and Full-Year 2017 Financial Results and Provides Business Update ACCESSWIRE -6.11%
12:00PM  CorMedix Inc. to Host Earnings Call ACCESSWIRE
Mar-13-18 08:00AM  CorMedix Inc. to Report Fourth Quarter and Full Year 2017 Financial Results on Monday, March 19 ACCESSWIRE
Mar-07-18 08:25AM  Investor Expectations to Drive Momentum within AVEO Pharmaceuticals, PTC Therapeutics, NGL Energy Partners LP, Bemis, CorMedix, and Patterson Companies Discovering Underlying Factors of Influence GlobeNewswire
Feb-27-18 09:15AM  CorMedix Inc. Provides Update on Its Financing Plans in Connection with Its Ongoing LOCK-IT 100 Clinical Study ACCESSWIRE
Feb-26-18 08:00AM  CorMedix Inc. Granted Orphan Drug Designation for Taurolidine for Treatment of Neuroblastoma ACCESSWIRE -5.90%
Feb-20-18 01:53PM  Why CorMedix Inc. (CRMD) Shares Took a Nosedive Today SmarterAnalyst -32.19%
07:30AM  CorMedix Inc. Achieves Target Number of Events in Its LOCK-IT-100 Study of Neutrolin(R) for Interim Efficacy Analysis ACCESSWIRE
Jan-01-18 11:31AM  ETFs with exposure to CorMedix, Inc. : January 1, 2018 Capital Cube
Dec-27-17 08:43AM  CorMedix, Inc. :CRMD-US: Earnings Analysis: Q3, 2017 By the Numbers : December 27, 2017 Capital Cube
Dec-19-17 12:35PM  ETFs with exposure to CorMedix, Inc. : December 19, 2017 Capital Cube
Dec-07-17 01:22PM  ETFs with exposure to CorMedix, Inc. : December 7, 2017 Capital Cube
Dec-05-17 08:05AM  CorMedix Inc. Announces Acceptance of Final Post-Marketing Study Data to be Published in the European Journal of Clinical Microbiology and Infectious Diseases ACCESSWIRE
Dec-04-17 04:20PM  CorMedix Inc (CRMD): Should The Recent EPS Drop Worry You? Simply Wall St. +17.60%
Nov-29-17 08:05AM  CorMedix Inc. to Host Seminar on Hemodialysis Catheter Complications at 17th Annual Conference on Nephrology ACCESSWIRE
Nov-20-17 08:20AM  CorMedix Inc. Announces Common Stock Purchase by Company Directors and Executive Management Team ACCESSWIRE
Nov-13-17 08:00AM  Factors of Influence in 2018, Key Indicators and Opportunity within CorMedix, RPC, Royal Caribbean Cruises, Callaway Golf, CIT Group, and Cars.com New Research Emphasizes Economic Growth GlobeNewswire -7.36%
Nov-09-17 04:15PM  CorMedix Inc. Reports Third Quarter Financial Results and Provides Business Update ACCESSWIRE
04:15PM  CorMedix Inc. Enters into $5 Million Combined Securities Purchase and Backstop Agreement with Existing Investor ACCESSWIRE
12:05PM  CorMedix Inc. to Host Earnings Call ACCESSWIRE
Nov-07-17 10:04AM  ETFs with exposure to CorMedix, Inc. : November 7, 2017 Capital Cube
08:05AM  CorMedix Inc. to Report Third Quarter 2017 Financial Results and Provide Business Update ACCESSWIRE
Oct-26-17 04:07PM  CorMedix Inc. to Present Candida auris Susceptibility Data at 2nd Annual Gulf Congress of Clinical Microbiology and Infectious Diseases ACCESSWIRE
Oct-12-17 10:23AM  ETFs with exposure to CorMedix, Inc. : October 12, 2017 Capital Cube -9.51%
Oct-11-17 07:34PM  Is There Now An Opportunity In CorMedix Inc (CRMD)? Simply Wall St. +15.76%
Sep-28-17 08:05AM  CorMedix Inc. to Present at The MicroCap Conference ACCESSWIRE
Sep-25-17 08:05AM  CorMedix Inc. Relocates Corporate Headquarters ACCESSWIRE
Sep-21-17 12:15PM  CorMedix Inc. to Present at The MicroCap Conference on October 5th in New York City at the Essex House ACCESSWIRE
Sep-12-17 08:17AM  CorMedix Inc. to Present at the Anti-Infectives Rx Conference ACCESSWIRE
Sep-07-17 04:05PM  CorMedix Inc. Presents Data Demonstrating Antimicrobial Activity of Taurolidine Against Potentially Deadly Fungal Pathogen Candida auris ACCESSWIRE
08:30AM  Are Options Traders Betting on a Big Move in CorMedix (CRMD) Stock? Zacks
Sep-05-17 04:45PM  CorMedix Inc. to Present at 2017 Rodman & Renshaw 19th Annual Global Investment Conference ACCESSWIRE -8.27%
Aug-31-17 05:55PM  ETFs with exposure to CorMedix, Inc. : August 31, 2017 Capital Cube
Aug-25-17 04:07PM  CorMedix Inc. Announces a Change to its Senior Leadership ACCESSWIRE +5.45%
Aug-24-17 10:37AM  CorMedix, Inc. :CRMD-US: Earnings Analysis: Q2, 2017 By the Numbers : August 24, 2017 Capital Cube
Aug-17-17 09:17AM  CorMedix, Inc. Awarded NIH Grant to Develop Advanced Antimicrobial Hydrogels for the Treatment and Prevention of Potentially Life-Threatening Infections in Severe Burns ACCESSWIRE +10.33%
Aug-16-17 08:36AM  Is the Options Market Predicting a Spike in CorMedix (CRMD) Stock? Zacks
Aug-09-17 04:10PM  CorMedix Inc. Reports Second Quarter Financial Results and Provides Business Update ACCESSWIRE
12:00PM  Investor Network: CorMedix Inc. to Host Earnings Call ACCESSWIRE
Aug-07-17 08:47AM  CorMedix Inc. Appoints Gary Gelbfish, M.D., to Board of Directors ACCESSWIRE +5.64%
Aug-04-17 02:46PM  CorMedix Inc. to Report Second Quarter 2017 Financial Results and Provide Business Update ACCESSWIRE
Aug-02-17 09:05AM  CorMedix Inc. Provides Update on Neutrolin(R) Ongoing Phase 3 Clinical Trial Following Favorable FDA Correspondence ACCESSWIRE +7.49%
Jul-14-17 08:32AM  Implied Volatility Surging For CorMedix Inc (CRMD) Stock Options Zacks
Jul-12-17 08:30AM  CorMedix Inc. Provides Comprehensive Pipeline Update During Research and Development Day Accesswire -5.17%
Jun-26-17 08:05AM  CorMedix Inc. Appoints Mehmood Khan, M.D. and Steven Lefkowitz to its Board of Directors Accesswire
Jun-23-17 08:47AM  Implied Volatility Surging for CorMedix (CRMD) Stock Options Zacks
Jun-16-17 03:35PM  ETFs with exposure to CorMedix, Inc. : June 16, 2017 Capital Cube -7.53%
Jun-14-17 09:15AM  CorMedix Inc. to Showcase Its Taurolidine-Based Development Pipeline at Research and Development Day Accesswire
Jun-12-17 11:13AM  CorMedix Inc. Announces Changes to Board of Directors Accesswire
May-31-17 09:00AM  Implied Volatility Surging for CorMedix (CRMD) Stock Options Zacks
May-26-17 01:03PM  ETFs with exposure to CorMedix, Inc. : May 26, 2017 Capital Cube
CorMedix, Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its primary focus is on the development of its lead product candidate, Neutrolin, an anti-infective solution for the reduction and prevention of catheter-related infections and thrombosis in patients requiring central venous catheters in clinical settings, such as dialysis, critical/intensive care, and oncology. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix, Inc. was founded in 2006 and is based in Berkeley Heights, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
ARMSTRONG JR. JOHN L.Exec VP of Tech OperationsDec 31Option Exercise0.0018,0290306,890Jan 03 04:02 PM
Lefkowitz Steven WDirectorDec 20Buy1.1820,00023,500135,757Dec 21 04:19 PM
Khan MehmoodDirectorDec 20Buy1.24100,000124,410564,583Dec 21 04:16 PM
Kaplan MyronDirectorDec 14Buy1.4750,00073,300431,166Dec 17 04:01 PM
Masson ElizabethEVP, Head of Clinical Ops.Dec 05Option Exercise0.2940,00011,60040,000Dec 06 04:19 PM
ARMSTRONG JR. JOHN L.Exec VP of Tech OperationsNov 29Buy1.45250,000363,150288,861Nov 30 04:04 PM
Baluch KhosoChief Executive OfficerNov 27Buy1.2121,50026,015250,373Nov 27 04:55 PM
Cook Robert W.Chief Financial OfficerNov 27Buy1.1725,00029,213127,083Nov 27 04:53 PM
Baluch KhosoChief Executive OfficerNov 26Buy1.283,5004,480228,873Nov 27 04:55 PM
Kaplan MyronDirectorNov 23Buy1.3050,00064,795371,166Nov 27 04:19 PM
Kaplan MyronDirectorNov 06Option Exercise0.005,0000321,166Nov 27 04:08 PM
Gelbfish Gary A.DirectorOct 12Option Exercise1.051,000,0001,050,0003,101,121Oct 16 05:07 PM
Kaplan MyronDirectorFeb 21Option Exercise0.0010,0000294,166Mar 22 04:03 PM
Dillione JanetDirectorFeb 21Option Exercise0.0015,3570107,409Mar 22 04:01 PM